Share-based Payment Arrangement, Expense of Kura Oncology, Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kura Oncology, Inc. quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Kura Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $10,965,000, a 32% increase year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Kura Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,965,000 +$2,641,000 +32% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $6,949,000 -$1,481,000 -18% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q3 2024 $8,324,000 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $8,430,000 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q2 2015 $485,000 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 $644,000 01 Jan 2015 31 Mar 2015 10-Q 13 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.